DO NOT SUBMIT OR FAX THIS PAGE TO COR F M L DD MM YY

Similar documents
APPENDIX F: CASE REPORT FORM

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

4. Which survey program does your facility use to get your program designated by the state?

Management of Acute Myocardial Infarction

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Acute Coronary Syndrome. Sonny Achtchi, DO

(For items 1-12, each question specifies mark one or mark all that apply.)

Acute Coronary Syndromes

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

2018 Acute Coronary Syndrome. Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

DISCUSSION QUESTION - 1

Acute Myocardial Infarction

Acute coronary syndromes

Acute Coronary Syndrome

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

Appendix: ACC/AHA and ESC practice guidelines

Quinn Capers, IV, MD

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Myocardial Infarction In Dr.Yahya Kiwan

Downloaded from:

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

GWTG Post-Discharge Follow-up Form

Acute Coronary Syndrome

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

SUPPLEMENTAL MATERIAL

Angina Luis Tulloch, MD 03/27/2012

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Results of Ischemic Heart Disease

CABG Surgery following STEMI

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

2010 ACLS Guidelines. Primary goals of therapy for patients

Cindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC

Diagnosis and Management of Acute Myocardial Infarction

ST-elevation myocardial infarctions (STEMIs)

Continuing Medical Education Post-Test

Supplementary Table 1. Details of the components of the primary composite endpoint

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

Practitioner Education Course

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Quality Payment Program: Cardiology Specialty Measure Set

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Acute Coronary syndrome

Non ST Elevation-ACS. Michael W. Cammarata, MD

EACTS Adult Cardiac Database

FastTest. You ve read the book now test yourself

Current Treatment Of Ischemic Heart Disease In the United States: An Overview. By Dr Gary Mo

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction

2018 HPN Provider Summary Guide. Adult Cardiology Patients (18 Years and Older) Referral Guidelines

A Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in Patients with Non-ST Elevation ACS

Acute Coronary Syndrome (ACS) Initial Evaluation and Management

Coronary Angiogram Database of South Australia

The PAIN Pathway for the Management of Acute Coronary Syndrome

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

Subsequent management and therapies

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

J. Schwitter, MD, FESC Section of Cardiology

Difficult Data Definitions and Scenario s

DUKECATHR Dataset Dictionary

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs

Protocols for the Management of Cardiac Conditions. By Pam Bayles, RN, BSN

Update on Antithrombotic Therapy in Acute Coronary Syndrome

Cardiogenic Shock. Carlos Cafri,, MD

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

CCRN Review Cardiovascular

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

Frans Van de Werf, MD, PhD Leuven, Belgium

Learning Objectives. Epidemiology of Acute Coronary Syndrome

ST ELEVATION MYOCARDIAL INFARCTION (STEMI) Gordon Kritzer, MD, FACC Virginia Mason Medical Center, Seattle

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

2012 Core Measures. Acute Myocardial Infarction (AMI)

THE CARDIOVASCULAR SYSTEM-PART 2

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

Controversies in Cardiac Pharmacology

convey the clinical quality measure's title, number, owner/developer and contact

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

Heart Failure Clinician Guide JANUARY 2016

Consensus Core Set: Cardiovascular Measures Version 1.0

Date of Meeting: Ratified Date: 03/06/2009

Clinical Case. Management of ACS Based on ACC/AHA & ESC Guidelines. Clinical Case 4/22/12. UA/NSTEMI: Definition

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Richard Grocott Mason

UTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Transcription:

DO NOT SUBMIT OR FAX THIS PAGE TO COR Patient # Patient Initials of Birth Medical Record Number F M L DD MM YY Patient Name Address Telephone (home) Telephone (work) Expected 6-month Follow-up Family Physician Name Address Telephone Cardiologist/Internist Name Address Telephone CRF Submitted to COR Corrections Returned (in response to QC Report) Corrections Returned (in response to QC Report) GRACE Initial Form Version 35 GRIn-35 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 http//wwwoutcomesorg

Summary of GRACE Eligibility Criteria Basic GRACE Eligibility Criteria Must have one of the Acute Coronary Syndromes as a presumptive diagnosis Must be 18 years of age or over The qualifying acute coronary syndrome must not have been precipitated or accompanied by a significant co-morbidity such as a motor vehicle accident, trauma, severe gastrointestinal bleeding, operation or procedure Patients who are already hospitalized when they develop qualifying ACS symptoms are not eligible for enrollment in GRACE Early Deaths Must be alive at the time of hospital presentation Patients hospitalized for less than 1 day who die may be enrolled provided that the cause of death is confirmed to be due to ACS Transfer Patients Patients transferred into or out of a registry hospital can be enrolled regardless of the time spent at the transferring hospital For patients transferred out of a registry hospital, data collection for the Initial CRF will end with the transfer and indication of purpose of transfer Patients can be enrolled more than once Patients may be re-enrolled provided that at least 6 months have passed since their prior enrollment When a patient is re-enrolled, a new GRACE patient identification number must be assigned Confirmation of Eligibility Symptoms felt to be consistent with acute cardiac ischemia within 24 hours of hospital presentation Plus, a minimum of 1 of the definitions for 1 (or more) of the following 4 criteria History of CAD History of Ml, angina, CHF felt to be due to ischemia or resuscitated sudden cardiac death History of positive stress test with/without imaging History of cardiac catheterization documenting CAD History of PCI or CABG New Documentation of CAD New positive stress test with/without imaging New cardiac catheterization documenting CAD New PCI or CABG ECG Changes Transient ST segment elevations of 1 mm ST segment depressions of 1 mm New T wave inversions of 1 mm Pseudo-normalization of previously inverted T waves New Q waves (1/3 the height of the R wave or 004 secs) New R wave >S wave in lead V 1 (posterior MI) New LBBB Increase in Cardiac Enzymes CKMB 2x upper limit of the hospital's normal range, OR if no CKMB available, then total CPK >2 x upper limit of the hospital's normal range Positive troponin I Positive troponin T A ENROLLMENT C MEDICAL HISTORY 2 Where Identified 15 Smoker 1 = CCU/ICU 1 = Former smoker 2 = Cath Lab 2 = Current smoker 3 = ER / ED 9 = Status not recorded 4 = Cardiac Unit 16 Diabetes 5 = General Unit 1 = Diet controlled 6 = Admit List 2 = Oral hypoglycemics 7 = Other 3 = Insulin-dependent 4 = treatment used 9 = Type not recorded 17 Renal Insufficiency 1 = Dialysis 2 = Dialysis

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) General Information Pt Initials F M L A Enrollment of Birth (Required) 1 9 1 Confirmation of Eligibility per GRACE Protocol (Fill in all that apply) Symptoms of Ischemia and History of CAD Qualifying ECG Changes New Documentation of CAD Positive Cardiac Enzymes 2 Pursuit Type (Fill in one) Cold Warm If warm, where identified?* B Demographics 1 Postal Code (Patient Residence) 2 Gender (Required) re Male Female 3 Admission Weight lb kg 4 Height in cm C Medical History (If to 15-17, please provide code*) 1 Angina 2 MI 3 CHF 4 Coronary Angiogram Diagnostic for CAD 5 PCI 6 CABG 7 Valve Repair/ Replacement 8 Family History of CAD 9 Positive Stress Test 10 Hypertension 11 Dyslipidemia 12 Peripheral Arterial Disease 13 Atrial Fib 14 TIA/Stroke 15 Smoker* 16 Diabetes* 17 Renal Insufficiency* 18 Major Surgery 19 Major Bleeding 20 Internal Cardiac Defibrillator (ICD) 21 History of Venous Thromboembolism D Presentation 1 Symptom Time Onset (Prompting Presentation to Hospital) 2 Hospital #1 Arrival (Required if not transferred) 3 BP 4 Pulse systolic GRACE Initial Form Version 35 GRIn-35 Page 1 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg / diastolic bpm 9519

D PRESENTATION 6 Killip Class 1 = I ( CHF) 2 = II (Rales) 3 = III (Pulmonary Edema) 4 = IV (Cardiogenic Shock) 7 Presumptive Admission Diagnosis 1 = Ml 2 = Unstable Angina 3 = Rule out Ml or suspected ACE/ACS 4 = Chest Pain 5 = Other Cardiac 6 = Other

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) D Presentation (continued) 5 Cardiac arrest at presentation? 7 Presumptive Admission Diagnosis* 9 If, Hospital #2 Arrival (Required if transferred) day 8 Was patient transferred from another hospital? month year 6 Killip Class* Time 10 Reason for transfer (Fill in all that apply) Acute Care Cardiac Cath PCI CABG Other D E ECG Presentation Findings(continued) 1a Index ECG (Prompted by ACS symptoms) Time Was Index ECG done in pre-hospital setting? 1b Was Index ECG abnormal for Ischemia? (Required) If, note abnormalities below ST (1mm) ST (1mm) Significant Q Waves T Wave Inversions 1c Other abnormalities? (Fill in all that apply) AV Block (Mobitz II, 3 ) Atrial Fib/Flutter Paced Rhythm Anterior Inferior Lateral Left Bundle Branch Block 1d Were any of the ischemic abnormalities on the index ECG new or presumed new? t Applicable (index ECG had no ischemic abnormalities) Unknown If, note new and presumed new abnormalities below ST (1mm) ST (1mm) Significant Q Waves T Wave Inversions Posterior Infarction nspecific ST/T Change Anterior Inferior Lateral Left Ventricular Hypertrophy Left Bundle Branch Block Vtach RBBB 1e Other new abnormalities? (Fill in all that apply) AV Block (Mobitz II, 3 ) Atrial Fib/Flutter Paced Rhythm Posterior Infarction nspecific ST/T Change Left Ventricular Hypertrophy Vtach RBBB GRACE Initial Form Version 35 GRIn-35 Page 2 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) E ECG Findings (continued) 2a Did the patient develop ST or LBBB after the index ECG? If, specify date and time day month 2b Did the patient develop any of the following after the index ECG? (Fill in all that apply) Significant Q Waves or R>S in V1 If, specify date and time day month year year Time Time ST Depressions (1mm) If, specify date and time T Wave Inversions If, specify date and time F Laboratory 1 Initial Creatinine umol/liter 3 Initial WBC 103 /cc 9 10 /L 2 Peak Creatinine umol/liter 4 Serum Cholesterol Prior to hospital presentation mmol/liter <24 hrs after hospital presentation 24 hrs after hospital presentation LDL mmol/liter HDL mmol/liter Triglycerides mmol/liter 5 Initial Glucose mmol/liter Fasting Glucose mmol/liter GRACE Initial Form Version 35 GRIn-35 Page 3 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

H1 CARDIAC CATH / INTERVENTIONS Culprit Lesion Territory 1 = LM 2 = LAD 3 = LCX 4 = RCA 5 = Vein Bypass Graft 6 = Arterial Bypass Graft 7 = Unknown Culprit Artery TIMI Flow 1 = Occluded (TIMI 0/1) 2 = Slow (TIMI 2) 3 = rmal (TIMI 3) 4 = Unknown

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) F Laboratory (continued) 6 Cardiac Markers - Initial Values 7 Cardiac Markers - Maximum Values in 1st 24 hrs CPK CK-MB CPK CK-MB CPK CK-MB ULN ULN and Time CPK ULN and Time CK-MB ULN Troponin I OR T Value Troponin I OR T Value ULN ULN and Time and Time 8 Biomarkers CRP BNP Homocysteine pcg/ml mg/l pg/ml mol/liter G Procedures 1 Pacemaker 2 Echocardiography 3 PA Catheter Type (Fill in all that apply) Temporary Permanent ICD 4 Ventilator 5 IABP 6 Stress Test Pos Neg H Cardiac Cath/Interventions Patient/Family Refused Procedure (Fill in all that apply) Cardiac Cath PCI CABG 1 Cardiac Cath Stenosis 50% in territories (Fill in all that apply) LM LAD LCX RCA Bypass Graft(s) Time Total # of Cath Procedures (during hospitalization) Culprit Lesion Stenosis % Culprit Lesion Territory* Culprit Artery TIMI Flow* GRACE Initial Form Version 35 GRIn-35 Page 4 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

H CARDIAC CATH / INTERVENTIONS 2 PCI Type 1 = Primary/direct (immediate mode of reperfusion in AMI) 2 = Rescue (after failed thrombolysis, where failed refers to ongoing/recurrent ischemic discomfort and/or lack of ST segment elevation resolution or recurrent ST elevation) 3 = Early PCI for cardiogenic shock 4 = PCI for treatment of unstable angina 5 = PCI for treatment of post AMI ischemia 6 = Facilitated PCI (immediate PCI following successful thrombolysis, or in conjunction with thrombolysis) 7 = n-emergent adjunctive PCI of non-culprit lesion (stayed) 8 = Other (including non-emergent elective PCI of suspected culprit lesion) 3 Type of Graft(s) 1 = Vein graft(s) 2 = Arterial graft(s) 3 = Both Vein and Arterial graft(s) I LVEF LVEF Grade 1 = rmal 2 = Mildly Diminished 3 = Moderately Diminished 4 = Severely Diminished LVEF How Obtained 1 = Ventriculogram (angiogram) 2 = Nuclear Imaging 3 = Echo

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) H Cardiac Cath/Interventions (continued) 2 PCI Time Total # of PCI Procedures (during hospitalization) Indicate for 1st PCI # of Dilated Vessels # of Stents PCI Type* 3 CABG Done with Brachytherapy Drug Coated Stent(s) If, Number Failed Procedure of Coated Stents # of Distal Graft(s) Type of Graft(s)* I LVEF LVEF % OR Grade* How obtained* J Thrombolytics Thrombolytics If, # of treatments of first Thrombolytics contraindicated Time 1 Name of First Thrombolytic Drug (Fill in one from below) Streptokinase t-pa r-pa TNK-tPA Other Blinded Study Drug Dose (Fill in one) half full 2 Thrombolytic Initiation Site (Fill in one) Pre-hospital In-hospital 3 Drugs administered simultaneously with thrombolytic (Fill in all that apply) GP IIb/IIIa LMWH Unfractionated Heparin Blinded Study Drug GRACE Initial Form Version 35 GRIn-35 Page 5 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

K ANTIPLATELETS / ANTITHROMBINS / ANTICOAGULANTS 14 IV GP IIlb/IIIa Reason for Administration 1 = With PCI (started before PCI) 2 = Without PCI (medical treatment) 3 = Rescue (instituted after start of PCI Sometimes referred to as bail-out use)

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) K Antiplatelets/Antithrombins/Anticoagulants (Fill in all that apply for each medication) Blinded Study Drug Chronic Use Pre-Hospital Acute Within 1st 24 hrs Hospital After 1st 24 hrs Hospital Peri-PCI Prescribed at Discharge t Prescribed 1 Aspirin (Required) dosage mg/day dosage mg/day 2 Warfarin or other Vitamin K Antagonist 3 Ticlopidine 4 Clopidogrel (Required) 5 Unfractionated Heparin 6 IV Enoxaparin 7 SQ Enoxaparin (Required) 8 Bivalirudin 9 Fondaparinux 10 Other Direct Thrombin Inhibitors 11 Other LMW Heparin 12 Other Antiplatelet 13 Other Antithrombin 14 IV GP llb/llla Reason for Administration* GP llb/llla simultaneous drug administration with (Fill in all that apply) Unfractionated Heparin LMWH GRACE Initial Form Version 35 GRIn-35 Page 6 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) L Other Medications (Fill in all that apply for each medication) Blinded Study Drug Chronic Use Pre-Hospital Acute OR Within 1st 24 hrs Hospital After 1st 24 hrs Hospital Prescribed at Discharge/ Transfer t Prescribed 1 ACE Inhibitor 2 Amiodarone 3 Angiotensin II Receptor Blocker (ARB) 4 Beta Blocker (IV) 5 Beta Blocker (Oral) 6 Calcium Channel Blocker 7 Digoxin 8 Diuretic 9 Glucose/Insulin/Potassium (GIK) 10 Inotropic Agent (IV) 11 Insulin 12 Insulin Provider 13 Insulin Sensitizer 14 Magnesium (IV) 15 Nitrate (IV) 16 Nitrate (Oral/Topical) 17 Nicorandil 18 Omega-3 Fatty Acids 19 Statin 20 Other Lipid Lowering Agent M Medication Contraindications (Fill in all that apply) ASA Beta Blockers ACE Inhibitors ARB Statins LMWH UFH N Lifestyle Interventions 1 If current cigarette smoker, was patient counseled to quit smoking by a health care professional? /Unknown Does t Apply 2 Was patient referred to a cardiac rehab program? /Unknown GRACE Initial Form Version 35 GRIn-35 Page 7 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519

O IN-HOSPITAL EVENTS 12 Mechanical Complications 1 = Ventricular Septal Defect 2 = Mitral Regurgitation 3 = Free wall rupture

9519 GRACE Initial Form v35 Site ID (Required) Patient ID (Required) O In-hospital Events After Presentation 1 Recurrent Ischemic Symptoms 2 CHF/Pulmonary Edema 3 Cardiogenic Shock 4 Cardiac Arrest/VF* If yes*, specify date 5 Atrial Fib/Flutter 6 Sustained VT 7 Thrombocytopenia 8 HIT 9 Venous Thromboembolism 10 Acute Renal Failure 11 AV Block (Mobitz II, 3 ) 12 Mechanical* Complication If yes*, enter Code 13 MI > 24 hrs after hospital presentation/re-infarction Confirmed by (Fill in all that apply) Cardiac Markers ECG Peri-procedural 14 Stroke CT/MRI Confirmed? Type (Fill in one) Embolic/Ischemic Embolic w/ Hemorrhagic Conversion Hemorrhagic/Subdural Hematoma Other 15 Major Bleeding (except hemorrhagic stroke) Site(s) (Fill in all that apply) Treatment (Fill in one) Surgery Transfusion Both Surgery and Transfusion ne P Discharge Status 1 Was patient treated as part of a research protocol? 2 Discharge Status (Required) Death Home Transfer to Another Acute Facility AMA/Self-Discharge Other For Specific Procedure? (Fill in all that apply) Cath PCI CABG 3 of Discharge 4 Time of Death or Death if Died (Required) (Required) 5 Primary Discharge Diagnosis - Fill in one (Required) ACS Other Cardiac Other Vascular Access Other Site Specify Other/Other Cardiac Diagnosis 6 Who was the primary physician who cared for the patient while in the hospital? (Fill in one) Cardiologist n-cardiologist If so, then Cardiology Consult? Forms Completed by day month year GRACE Initial Form Version 35 GRIn-35 Page 8 of 8 2002-2006 Center for Outcomes Research UMass Medical School Worcester, MA 01605 (508) 856-0081 htp/wwwoutcomesorg 9519